How does the AHA PREVENT model compare to the WHO risk model in reclassifying cardiovascular-kidney-metabolic risk in South Asia?
No direct evidence for comparing the AHA PREVENT model versus the WHO risk model in reclassifying cardiovascular-kidney-metabolic risk in South Asia exists. Individual risk assessment tools should be chosen with careful consideration of the patient's specific risk profile and clinical context.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-10-29
- DOI
- https://doi.org/10.5281/zenodo.23755308
- Primary Topic
- Health Promotion and Cardiovascular Prevention
- Type
- article
- Field-Weighted Citation Impact
- 0.00